{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T04:40:54Z","timestamp":1760157654302,"version":"build-2065373602"},"reference-count":41,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T00:00:00Z","timestamp":1744675200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Orthopaedics &amp; Traumatology: Surgery &amp; Research"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.otsr.2025.104242","type":"journal-article","created":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T02:26:23Z","timestamp":1744165583000},"page":"104242","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Is there a cardiovascular risk associated with the use of fluoroquinolones for the treatment of osteoarticular infections? Analysis of a retrospective cohort of 817 patients from a surgical and infectious disease referral center (CRIOAC)"],"prefix":"10.1016","volume":"111","author":[{"given":"Malo","family":"Buisson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2955-0589","authenticated-orcid":false,"given":"Philippe-Alexandre","family":"Faure","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barthelemy","family":"Lafon Desmurs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Loiez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Valentin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henri","family":"Migaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Senneville","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.otsr.2025.104242_bib0005","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.semarthrit.2018.01.007","article-title":"Analysis of mortality in a cohort of 650 cases of bacteremic osteoarticular infections","volume":"48","author":"Gomez-Junyent","year":"2018","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.otsr.2025.104242_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.otsr.2022.103453","article-title":"One- or two-stage reimplantation for infected total knee prosthesis?","volume":"109","author":"Wignadasan","year":"2023","journal-title":"Orthop Traumatol Surg Res"},{"key":"10.1016\/j.otsr.2025.104242_bib0015","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.otsr.2018.09.016","article-title":"The CRIOAc Healthcare network in France: A nationwide Health Ministry program to improve the management of bone and joint infection","volume":"105","author":"Ferry","year":"2019","journal-title":"Orthop Traumatol Surg Res"},{"key":"10.1016\/j.otsr.2025.104242_bib0020","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jinf.2020.12.010","article-title":"Epidemiology of complex bone and joint infections in France using a national registry: the CRIOAc network","volume":"82","author":"Lemaignen","year":"2021","journal-title":"J Infect"},{"key":"10.1016\/j.otsr.2025.104242_bib0025","article-title":"Performance of the GeneXpert\u00ae MRSA\/SA SSTI test in periprosthetic joint infections: rate of failure, outcomes and risk factors","author":"Leclerc","year":"2024","journal-title":"Orthop Traumatol Surg Res"},{"key":"10.1016\/j.otsr.2025.104242_bib0030","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/S0140-6736(14)61798-0","article-title":"Periprosthetic joint infection","volume":"387","author":"Kapadia","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.otsr.2025.104242_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.otsr.2023.103642","article-title":"One-stage revision hip arthroplasty for infection using primary cementless stems as first-line implants: about 35 cases","volume":"109","author":"Mangin","year":"2023","journal-title":"Orthop Traumatol Surg Res"},{"key":"10.1016\/j.otsr.2025.104242_bib0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.otsr.2024.103820","article-title":"Accuracy of the GeneXpert\u00ae MRSA\/SA SSTI test to diagnose methicillin-resistant Staphylococcus spp. infection in bone fixation and fusion and management of infected non-unions","volume":"110","author":"Martin","year":"2024","journal-title":"Orthop Traumatol Surg Res"},{"key":"10.1016\/j.otsr.2025.104242_bib0045","article-title":"One-stage exchange strategy with extensive debridement for chronic periprosthetic joint infection following total knee arthroplasty is associated with a low relapse rate in non-selected patients: a prospective single-center analysis","author":"Pioger","year":"2024","journal-title":"Orthop Traumatol Surg Res"},{"key":"10.1016\/j.otsr.2025.104242_bib0050","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.cmi.2019.08.006","article-title":"Pathogenesis and management of fracture-related infection","volume":"26","author":"Depypere","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.otsr.2025.104242_bib0055","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.jbspin.2020.07.012","article-title":"2020 French recommendations on the management of septic arthritis in an adult native joint","volume":"87","author":"Couderc","year":"2020","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.otsr.2025.104242_bib0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.otsr.2022.103512","article-title":"Evolution of antibiotic susceptibility profiles of staphylococci from osteoarticular infections: a 10-year retrospective study","volume":"109","author":"Duployez","year":"2023","journal-title":"Orthop Traumatol Surg Res"},{"issue":"Suppl 1","key":"10.1016\/j.otsr.2025.104242_bib0065","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/jac\/dkg208","article-title":"The quinolones: decades of development and use","volume":"51","author":"Emmerson","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.otsr.2025.104242_bib0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.otsr.2024.103942","article-title":"Bone consolidation under septic condition and hardware retention: about 69 patients","volume":"110","author":"Dabert","year":"2024","journal-title":"Orthop Traumatol Surg Res"},{"key":"10.1016\/j.otsr.2025.104242_bib0075","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-010077","article-title":"Fluoroquinolones and collagen associated severe adverse events: a longitudinal cohort study","volume":"5","author":"Daneman","year":"2015","journal-title":"BMJ Open"},{"key":"10.1016\/j.otsr.2025.104242_bib0080","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1001\/jamaneurol.2019.0887","article-title":"Association between peripheral neuropathy and exposure to oral fluoroquinolone or amoxicillin-clavulanate therapy","volume":"76","author":"Morales","year":"2019","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.otsr.2025.104242_bib0085","first-page":"103","article-title":"QT Prolongation and torsade de pointes induced by fluoroquinolones: infrequent side effects from commonly used medications","volume":"120","author":"Briasoulis","year":"2011","journal-title":"CRD"},{"key":"10.1016\/j.otsr.2025.104242_bib0090","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1001\/jama.2012.383","article-title":"Oral fluoroquinolones and the risk of retinal detachment","volume":"307","author":"Etminan","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.otsr.2025.104242_bib0095","article-title":"Do fluoroquinolones increase aortic aneurysm or dissection incidence and mortality? A systematic review and meta-analysis","volume":"9","author":"Chen","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.otsr.2025.104242_bib0100","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-90692-8","article-title":"The association between fluoroquinolones and aortic dissection and aortic aneurysms: a systematic review and meta-analysis","volume":"11","author":"Wee","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.otsr.2025.104242_bib0105","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12872-020-01354-y","article-title":"Relationship between fluoroquinolones and the risk of aortic diseases: a meta-analysis of observational studies","volume":"20","author":"Dai","year":"2020","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.otsr.2025.104242_bib0110","first-page":"185","article-title":"Fluoroquinolones and the risk of aortopathy: a systematic review and meta-analysis","volume":"119","author":"Latif","year":"2020","journal-title":"WMJ"},{"issue":"20","key":"10.1016\/j.otsr.2025.104242_bib0115","article-title":"Fluoroquinolones are associated with increased risk of aortic aneurysm or dissection: systematic review and meta-analysis","volume":"S1043-0679","author":"Vouga Ribeiro","year":"2020","journal-title":"Semin Thorac Cardiovasc Surg"},{"key":"10.1016\/j.otsr.2025.104242_bib0120","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.ijcard.2018.09.067","article-title":"Fluoroquinolones and the risk of aortopathy: a systematic review and meta-analysis","volume":"274","author":"Noman","year":"2019","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.otsr.2025.104242_bib0125","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2174\/1871525717666190402121958","article-title":"Fluoroquinolones and the risk of aortic aneurysm or aortic dissection: a systematic review and meta-analysis","volume":"17","author":"Rawla","year":"2019","journal-title":"Cardiovasc Hematol Agents Med Chem"},{"key":"10.1016\/j.otsr.2025.104242_bib0130","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1007\/s40264-019-00828-z","article-title":"Fluoroquinolone use and the risk of collagen-associated adverse events: a systematic review and meta-analysis","volume":"42","author":"Yu","year":"2019","journal-title":"Drug Saf"},{"key":"10.1016\/j.otsr.2025.104242_bib0135","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.amjmed.2017.06.029","article-title":"Aortic dissection and aortic aneurysms associated with fluoroquinolones: a systematic review and meta-analysis","volume":"130","author":"Singh","year":"2017","journal-title":"Am J Med"},{"key":"10.1016\/j.otsr.2025.104242_bib0140","doi-asserted-by":"crossref","first-page":"k678","DOI":"10.1136\/bmj.k678","article-title":"Fluoroquinolone use and risk of aortic aneurysm and dissection: nationwide cohort study","volume":"360","author":"Pasternak","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.otsr.2025.104242_bib0145","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1001\/jamainternmed.2015.5389","article-title":"Risk of aortic dissection and aortic aneurysm in patients taking oral fluoroquinolone","volume":"175","author":"Lee","year":"2015","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.otsr.2025.104242_bib0150","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1001\/jamasurg.2020.6165","article-title":"Association of fluoroquinolone use with short-term risk of development of aortic aneurysm","volume":"156","author":"Newton","year":"2021","journal-title":"JAMA Surg"},{"key":"10.1016\/j.otsr.2025.104242_bib0155","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/j.jacc.2019.07.035","article-title":"Oral fluoroquinolones and risk of mitral and aortic regurgitation","volume":"74","author":"Etminan","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.otsr.2025.104242_bib0160","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1093\/eurheartj\/ehab374","article-title":"Oral fluoroquinolones and risk of aortic or mitral regurgitation: a nationwide nested case-control study","volume":"42","author":"Strange","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.otsr.2025.104242_bib0165","unstructured":"Information de s\u00e9curit\u00e9 - Fluroquinolones par voie syst\u00e9mique o. ANSM n.d. https:\/\/ansm.sante.fr\/informations-de-securite\/fluroquinolones-par-voie-systemique-ou-inhalee-risque-de-survenue-danevrisme-et-de-dissection-aortique (accessed November 25, 2024)."},{"key":"10.1016\/j.otsr.2025.104242_bib0170","unstructured":"Quinolone- and fluoroquinolone-containing medicinal products - referral | European Medicines Agency (EMA) 2018. https:\/\/www.ema.europa.eu\/en\/medicines\/human\/referrals\/quinolone-fluoroquinolone-containing-medicinal-products (accessed November 25, 2024)."},{"key":"10.1016\/j.otsr.2025.104242_bib0175","unstructured":"Commissioner O of the. FDA In Brief: FDA warns that fluoroquinolone antibiotics can cause aortic aneurysm in certain patients. FDA 12\/20\/2018. FDA warns about increased risk of ruptures or tears in the aorta blood vessel with fluoroquinolone antibiotics in certain patients | FDA (accessed November 25, 2024)."},{"key":"10.1016\/j.otsr.2025.104242_bib0180","doi-asserted-by":"crossref","DOI":"10.1001\/jamasurg.2018.1804","article-title":"Effect of ciprofloxacin on susceptibility to aortic dissection and rupture in mice","volume":"153","author":"LeMaire","year":"2018","journal-title":"JAMA Surg"},{"key":"10.1016\/j.otsr.2025.104242_bib0185","doi-asserted-by":"crossref","DOI":"10.1111\/ijcp.13331","article-title":"Assessing fluoroquinolone-associated aortic aneurysm and dissection: data mining of the public version of the FDA adverse event reporting system","volume":"73","author":"Meng","year":"2019","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.otsr.2025.104242_bib0190","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1007\/s11606-018-4774-2","article-title":"What fluoroquinolones have the highest risk of aortic aneurysm? A case\/non-case study in VigiBase\u00ae","volume":"34","author":"Sommet","year":"2019","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.otsr.2025.104242_bib0195","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1016\/j.jacc.2021.02.047","article-title":"Effects of fluoroquinolones on outcomes of patients with aortic dissection or aneurysm","volume":"77","author":"Chen","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.otsr.2025.104242_bib0200","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1001\/jamainternmed.2020.4199","article-title":"Association of fluoroquinolones with the risk of aortic aneurysm or aortic dissection","volume":"180","author":"Gopalakrishnan","year":"2020","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.otsr.2025.104242_bib0205","doi-asserted-by":"crossref","DOI":"10.1001\/jamainternmed.2020.4192","article-title":"Association of infections and use of fluoroquinolones with the risk of aortic aneurysm or aortic dissection","author":"Dong","year":"2020","journal-title":"JAMA Intern Med"}],"container-title":["Orthopaedics &amp; Traumatology: Surgery &amp; Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877056825000891?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877056825000891?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T04:15:14Z","timestamp":1760156114000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877056825000891"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":41,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S1877056825000891"],"URL":"https:\/\/doi.org\/10.1016\/j.otsr.2025.104242","relation":{},"ISSN":["1877-0568"],"issn-type":[{"type":"print","value":"1877-0568"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is there a cardiovascular risk associated with the use of fluoroquinolones for the treatment of osteoarticular infections? Analysis of a retrospective cohort of 817 patients from a surgical and infectious disease referral center (CRIOAC)","name":"articletitle","label":"Article Title"},{"value":"Orthopaedics & Traumatology: Surgery & Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.otsr.2025.104242","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"104242"}}